Sign Up Today and Learn More About Eight Sleep Stock
Invest in or calculate the value of your shares in Eight Sleep or other pre-IPO companies through EquityZen's platform.
About Eight Sleep Stock
Founded
2014
Headquarters
New York, NY, US
Total Funding
156M
Industries
Hardware, Health Care, Consumer Electronics
Eight Sleep is a sleep fitness company. Eight Sleep aims to leverage innovation, technology, and personal biometrics to restore individuals to their peak energy levels each morning. Eight Sleep sells "Sleep Pods," technology-enabled mattresses with a companion analytics app for mobile devices. Eight Sleep also sells mattress covers and other sleep accessories.
Eight Sleep was founded in 2014 and is headquartered in New York, New York. Notable investors include Y Combinator, SoftBank, and Stanford University.
Eight Sleep Press Mentions
Stay in the know about the latest news on Eight Sleep
Eight Sleep Expands Its Sleep Technology Platform With New Pod Pillow Cover
uaereview • Oct 01, 2025
Eight Sleep Expands Its Sleep Technology Platform With New Pod Pillow Cover
morningstar • Oct 01, 2025
Eight Sleep raises $100 million to boost AI sleep tech, medical expansion
arabianbusiness • Sep 29, 2025
Eight Sleep's Alexandra Zatarian Turns Sleep into a Competitive Sport
newsweek • Sep 29, 2025
Sleep Disorder Market Size to Exceed USD 88,970 Million by 2034 Driven by Rising Sleep Issues and Tech Advancements
globenewswire • Sep 25, 2025
Investors in Eight Sleep
Discover investors in Eight Sleep stock and explore their portfolio companies
Eight Sleep Management
Leadership team at Eight Sleep
Chief Executive Officer
Matteo Franceschetti
Chief Technology Officer
Massimo Andreasi Bassi
Join now and verify your accreditation status to gain access to:
- Eight Sleep Current Valuation
- Eight Sleep Stock Price
- Eight Sleep Management
- Available deals in Eight Sleep and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Eight Sleep Cap Table and Funding History by Share Class and Liquidity Preferences
- Eight Sleep Revenue and Financials
- Eight Sleep Highlights
- Eight Sleep Business Model
- Eight Sleep Risk Factors
- Eight Sleep Research Report from SACRA Research
Eight Sleep Key Facts
- Major Funding Fuels Innovation and Growth: Eight Sleep secured $100 million in new funding in August 2025, bringing total capital raised to $260 million. This investment enables faster international expansion, accelerated development of its AI-powered Sleep Agent, and entry into medical applications like menopausal sleep and sleep apnea, strengthening the company’s position as a sleep technology leader.
- Product and Data Leadership Drive Market Differentiation: Eight Sleep’s Pod product line has achieved over $500 million in sales, with company revenue growing tenfold since 2019 and over 1 billion hours of sleep data analyzed. Innovations such as Health Check and Autopilot provide highly personalized, real-time sleep and health optimization—establishing Eight Sleep as a premium brand trusted by professional athletes and high performers globally.Â
- Global Expansion and Regulatory Momentum: With its products now sold in over 30 countries and entry into China underway, Eight Sleep is rapidly expanding its global footprint. The company is also actively pursuing FDA clearance for medical-grade applications, positioning itself to access new healthcare markets and insurance reimbursement channels, which could transform future growth potential and operational scale.Â
- Privacy and Security Concerns: Eight Sleep was criticized by researcher Dylan Ayrey, who states that their mattresses pose a privacy risk. Because the mattress needs a wifi connection to work it could theoretically allow the company's engineers to access a backdoor to remote into any bed and run code on it without oversight. While the company stated that this setup was only for debugging, it could pose a risk of customer data being accessed without authorization and lead to security threats for the company.
- Macroeconomic Pressures and Sales Forecast Uncertainty: Although Eight Sleep projects a 5–10% revenue growth for 2025 following a flat sales period in mid-2024, persistent macroeconomic headwinds and changing consumer spending patterns across global retail threaten to disrupt these forecasts. Economic uncertainty could impact demand for premium smart sleep products, affecting future revenue and investment priorities.Â
- Regulatory and Medical Device Approval Risks: The company is actively seeking FDA clearance for its sleep apnea and menopause monitoring technologies, aiming to reposition its smart mattresses into the clinical market as medical devices. Regulatory delays or failure to secure these designations could hinder access to insurance reimbursement, slow healthcare adoption, and limit expansion into regulated wellness segments.
Trading Eight Sleep Stock
How to invest in Eight Sleep stock?
Accredited investors can buy pre-IPO stock in companies like Eight Sleep through EquityZen funds. These investments are made available by existing Eight Sleep shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Eight Sleep stock?
Shareholders can sell their Eight Sleep stock through EquityZen's private company marketplace. EquityZen's network includes over 390K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 48K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
